Advanced Biodesign
France - Saint-PriestBiotechnology
Focus: Advanced Biodesign is a French biotechnology company focused on ALDH inhibitors for oncology applications. The company operates as a pre-revenue biotech with a single Phase 1/2 program in acute myeloid leukemia.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Advanced Biodesign
AI assessmentNot HiringNo open roles listed right now. Follow Advanced Biodesign to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ABD-3001
Acute Myeloid Leukemia, AdultClinical Trials (1)
NCT05601726First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Phase 1/2Help build intelligence for Advanced Biodesign
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.